125 related articles for article (PubMed ID: 2856855)
1. Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):699-706. PubMed ID: 2856855
[No Abstract] [Full Text] [Related]
2. Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
Fisher B
Recent Results Cancer Res; 1986; 103():54-68. PubMed ID: 3526476
[No Abstract] [Full Text] [Related]
3. Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):750-5. PubMed ID: 3904232
[No Abstract] [Full Text] [Related]
4. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Jones SE; Moon TE
Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768
[No Abstract] [Full Text] [Related]
5. A brief overview of findings from NSABP trials of adjuvant therapy.
Fisher B; Fisher ER; Redmond C
Recent Results Cancer Res; 1984; 96():55-65. PubMed ID: 6101262
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy in primary breast cancer.
Wolmark N; Fisher B
Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
[No Abstract] [Full Text] [Related]
8. Eight-year follow-up of adjuvant therapy for stage II breast cancer.
Hubay CA; Gordon NH; Pearson OH; Marshall JS; McGuire WL
World J Surg; 1985 Oct; 9(5):738-49. PubMed ID: 3904231
[No Abstract] [Full Text] [Related]
9. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.
Fisher B; Redmond C; Wickerham DL; Bowman D; Schipper H; Wolmark N; Sass R; Fisher ER; Jochimsen P; Legault-Poisson S
J Clin Oncol; 1989 May; 7(5):572-82. PubMed ID: 2651576
[TBL] [Abstract][Full Text] [Related]
10. Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Jones SE; Brooks RJ; Takasugi BJ; Garewal HS; Giordano GF; Ketchel SJ; Jackson R; Heusinkveld RS; Kemmer SR; Moon TE
Recent Results Cancer Res; 1984; 96():133-40. PubMed ID: 6396766
[No Abstract] [Full Text] [Related]
11. A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.
Wood WC; Weiss RB; Tormey DC; Holland JF; Henry PH; Leone LA; Rafla S; Silver RT; Carey RW; Lesnick GJ
World J Surg; 1985 Oct; 9(5):714-8. PubMed ID: 3840627
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Carter SK
Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
[No Abstract] [Full Text] [Related]
13. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
Sorace RA; Bagley CS; Lichter AS; Danforth DN; Wesley MW; Young RC; Lippman ME
World J Surg; 1985 Oct; 9(5):775-85. PubMed ID: 2998103
[No Abstract] [Full Text] [Related]
14. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
15. Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.
Hryniuk WM; Levine MN; Levin L
NCI Monogr; 1986; (1):87-94. PubMed ID: 3534595
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancer.
Zielinski CC; Kubista E; Salzer H; Sevelda P; Langer M; Staffen A; Spona J; Aiginger P
Lancet; 1986 Nov; 2(8516):1164. PubMed ID: 2877314
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy of breast cancer.
Cooper RG
Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
[No Abstract] [Full Text] [Related]
18. Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients.
Jacquillat C; Weil M; Auclerc G; Auclerc MF; Khayat D; Baillet F
Recent Results Cancer Res; 1989; 115():36-42. PubMed ID: 2516351
[No Abstract] [Full Text] [Related]
19. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
20. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
